Explore evidence

43.1 %47 (43.1%) patients are supposed to express the RH10 (V) low-frequency antigen.

CameroundrépanocytoseHAL · Unilimdocument of 45 observations

97.6 %Concordance between predicted RH phenotype and serologic testing was 97.6% for the five major RH antigens.

CameroundrépanocytoseHAL · Unilimdocument of 45 observations

40 %There was a much higher allele frequency of the 3.7-kb α-globin gene deletion in SCD patients (∼ 40%) than in haemoglobin AA controls (∼ 10%).

Cameroundrépanocytosepublished 2015Public health genomicseurope_pmcdocument of 6 observations

1 patientRH30 (Goa) low-frequency antigen is predicted in one patient.

CameroundrépanocytoseHAL · Unilimdocument of 45 observations

53.2 %58 (53.2%) patients are supposed to express the RH20 (VS) low-frequency antigen.

CameroundrépanocytoseHAL · Unilimdocument of 45 observations

97.2 %RH1 antigen expression was predicted in 97.2% of the subset of patients.

CameroundrépanocytoseHAL · Unilimdocument of 45 observations

77.1 %Among 109 Cameroonian patients with sickle cell disease (SCD), 84/109 samples (77.1%) supposedly expressed a 'normal' D-positive phenotype.

CameroundrépanocytoseHAL · Unilimdocument of 45 observations

2,409 patientsAmong 2409 sickle cell disease patients in the CADRE cohort from Ivory Coast, Cameroon, and Mali, 1751 had the SS-Sβ0 phenotype and 658 had the SC-Sβ+ phenotype.

Cameroun · Côte d'Ivoire · Malidrépanocytosepublished 2015BloodOpenAlexdocument of 16 observations

15 yearsThe median age of 413 Sickle Cell Disease patients from Cameroon was 15 years.

Cameroundrépanocytosepublished 2017British journal of haematologyeurope_pmcdocument of 3 observations

4 patientsRH31 (hrB) high-frequency antigen is thought to be defective in 4 to 16 patients.

CameroundrépanocytoseHAL · Unilimdocument of 45 observations

53.2 %58 out of 109 patients (53.2%) were predicted to express the RH20 (VS) low-frequency antigen.

CameroundrépanocytoseHAL · Unilimdocument of 45 observations

36.1 %Contrary to Cameroonian doctors who considered termination of an affected pregnancy (TAP) for SCD in 36.1%, the majority of parents (62.5%) with affected children accepted TAP in principle.

Cameroundrépanocytosepublished 2015Public health genomicseurope_pmcdocument of 6 observations

43.1 %47 out of 109 patients (43.1%) were predicted to express the RH10 (V) low-frequency antigen.

CameroundrépanocytoseHAL · Unilimdocument of 45 observations

6.7 %The prevalence of overt stroke among SCD patients in Cameroon was 6.7%.

CamerounAVC · drépanocytosepublished 2015Cardiovascular journal of Africaeurope_pmcdocument of 2 observationsDOI 10.5830/cvja-2015-040

49.5 %Among 413 Sickle Cell Disease patients from Cameroon, 49.5% (n = 200) presented with glomerular hyperfiltration.

Cameroundrépanocytosepublished 2017British journal of haematologyeurope_pmcdocument of 3 observations

8.34 %Le Cameroun a un taux de prévalence de 8,34 % de la drépanocytose dans la population générale.

CameroundrépanocytoseHAL · Unilimdocument of 75 observations

87.7 %The RHCE*01 (*ce) allelic background was the most prevalent among Cameroonian patients with sickle cell disease (SCD), with No.=189 (87.7%).

Cameroundrépanocytoseobserved 2023HAL · Unilimdocument of 45 observations

99.1 %RH4 antigen expression was predicted in 99.1% of the subset of patients.

CameroundrépanocytoseHAL · Unilimdocument of 45 observations

612 patients612 sickle cell disease patients and 149 healthy controls were included in the CADRE study in Cameroon, Mali, and Senegal.

Cameroun · Mali · SénégaldrépanocytoseHAL · Unilimdocument of 2 observations

37 %Serologic testing yielded 40 false-negative samples (37.0%) for RH5 antigen testing.

CameroundrépanocytoseHAL · Unilimdocument of 45 observations

20,000 FFLe coût mensuel de la prise en charge thérapeutique par enfant malade de drépanocytose au Cameroun peut atteindre 20 000 FF en fonction du nombre de crises survenues dans le mois.

CameroundrépanocytoseHAL · Unilimdocument of 75 observations

6 %Chez les patients atteints de drépanocytose âgés de 7 mois à 35 ans au Cameroun, la prévalence d’accident vasculaire cérébral est de 6 à 7 %.

CamerounAVC · drépanocytoseHAL · Unilimdocument of 75 observations

70 %Au Cameroun, 70 % d’enfants atteints de drépanocytose décèdent avant l’âge de 5 ans.

CameroundrépanocytoseHAL · Unilimdocument of 75 observations

3 hospitalisations_par_moisAu Cameroun, la fréquence des hospitalisations pour drépanocytose est estimée à entre 3 et 4 hospitalisations par mois chez les enfants de moins de 5 ans.

CameroundrépanocytoseHAL · Unilimdocument of 75 observations

150 FFLe coût mensuel de la prise en charge thérapeutique par enfant malade de drépanocytose au Cameroun peut varier de 150 à 1000 FF selon que l’enfant est en crise ou non, en fonction de la gravité de la crise et de sa durée.

CameroundrépanocytoseHAL · Unilimdocument of 75 observations